DB05452ExperimentalSmall molecule
PH-284 belongs to a new family of new chemical entities called vomeropherins. Vomeropherins are self-administered by the patient with a metered nasal spray, or nasal aerosol device so that they... This binding produces neural impulses that are transmitted by specific pathways to the hypothalamic centre that directly and rapidly affect brain function.
- Mechanism
- Curator reviewed
Vomeropherins bind to peripheral chemosensory receptors in the vomeronasal organ.
- Primary indication
- Investigated for use/treatment in anorexia and other conditions causing harmful weight loss.Curator reviewed
- Code names
- PH-284
Resolves to
Targets
What you can answer from here — as of April 02, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with PH-284, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account